|
> Click here to find out about new medicines in development
New Site Details Promise, Implications of Personlized Medicine. > More
More than 400 new medicines are in development to treat diseases that affect women. > More
399 medicines in development offer hope in the war on cancer. > More
Medicines reducing the need for more care for everything from ulcers and heart disease to Alzheimer’s. > More
More About Breakthrough Medicines:
- New Facts on the Value of Medicines New medicines help avert surgeries and trips to the ER, prevent disability, and improve quality of life for patients everywhere. The benefits ripple beyond individual patients to society in general. The charts in this book illustrate the diverse and far-reaching benefits of prescription medicines.
- R&D Investments by America’s Pharmaceutical Research Companies Nears Record $40 Billion in 2005 New statistics released today show that R&D investments in new medicines by PhRMA’s biotechnology and pharmaceutical research member companies reached a record $39.4 billion in 2005 (up from $37 billion in 2004).
- Report: More Than 900 Medicines Are in Testing To Combat Diseases of Aging A new survey finds more than 900 medicines in development for diseases of aging, including 146 for heart disease and stroke, 399 for cancer, and 373 for such debilitating diseases as Alzheimer’s, diabetes, and osteoporosis.
- Report: A Decade of Innovation A study examining the past decade’s innovations in treatments for rheumatoid arthritis (RA), HIV/AIDS, Parkinson’s disease, Alzheimer’s disease, schizophrenia, diabetes, high blood pressure, and high blood cholesterol.
- More Than 400 Medicines Are in Testing for Diseases of Major Concern to American Women Pharmaceutical researchers are developing 446 medicines for diseases that disproportionately affect American women. This recent report by PhRMA details potential new medicines in the pipeline for women (either in clinical trials or awaiting approval at the Food and Drug Administration).
|
